gene therapy

Glybera gene therapy helps treat rare diseases and has yielded very positive results.

In the near future, using gene therapy, human deafness will be completely cured.

Scientists from the Stanford University's Bio-X division have used gene therapy to manipulate mice, so light can be used on the legs of mice to alter the sensitivity of the pain.

New trials of gene therapy for Parkinson's disease have shown encouraging results, giving hope to millions of people with this paralysis syndrome worldwide.

The British Journal of Natural Medicine released Feb. 4, scientists at Rosalind Franklin University of Medicine and Science in the United States have recovered some of their

In a statement released on November 5, Dutch biotech company uniQure said it would start selling the first human gene therapy called Glybera in the European market next year.

For the first time in a laboratory a gene therapy has successfully restored olfactory ability in mice, opening new hopes for treating congenital olfactory loss or human illness.

Recent medical researchers have studied the application of gene therapy in the treatment of erectile dysfunction. They also claim that this treatment can also cure some other

British scientists believe that the gene therapy they just developed may open up hope to cure the agonist syndrome - Parkinson's disease, which is affecting 4.1 million patients

In the magazine